TPA


Also found in: Dictionary, Thesaurus, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.

tPA

 
tissue-type plasminogen activator.

TPA

 (t-PA)
2. total parenteral alimentation (see parenteral nutrition); t-plasminogen activator.

TPA

, tPA

TPA

,

t-PA

tissue plasminogen activator.

tPA

or

TPA

abbr.
tissue plasminogen activator

TPA

abbreviation for tissue plasminogen activator.

PLAT

A gene on chromosome 8p12 that encodes tissue plasminogen activator, which converts inactive plasminogen to plasmin by hydrolysing a single Arg-Val bond in plasminogen, thereby playing a key role in tissue remodelling, degradation, cell migration and other cellular events. PLAT directly facilitates neuronal migration.

tPA

Abbreviation for tissue plasminogen activator.

TPA

Abbrev. for TISSUE-PLASMINOGEN ACTIVATOR.

Tissue plasminogen activator (tPA)

A substance that is sometimes given to patients within three hours of a stroke to dissolve blood clots within the brain.
Mentioned in: Stroke

TPA

total parenteral alimentation; see parenteral nutrition.
References in periodicals archive ?
This incentive to partner closely with one another so each can deliver services accurately and seamlessly in support of shared plan sponsor clients is borne out by the fact that more than 70% of TPA firms responding to the first PLANSPONSOR Third-Party Administrator Survey, this year, have no affiliated recordkeeping platform, needing instead to place business with strategic partners' platforms.
Minimizing Litigation Engaging in a robust TPA selection process takes time away from addressing the day-to-day demands of administering the plan and responding to participant needs.
As an independent physician, you can grow your business and stay independent by working with your local self-funded employers and their TPAs to treat employees.
Bernstein: In many instances the TPA is the buffer between the client and their customers.
Table-II demonstrates that the mean serum levels of both TPA and IL-6 were significantly higher in breast cancer patients than healthy control group.
We pretreated cells with 10[micro]M U0126 (a MEK1/2 inhibitor), SB253580 (a p38 inhibitor), or LY294002 (a PI3-kinase inhibitor) prior to treatment with 10 nM TPA for 30min, and then further incubated the cells for 24h.
The infrastructure necessary to operate a major national TPA is so expensive that only a handful of companies can afford to make a go of it and expect to survive.
I don't know if this is going to be enough to convince the confirmed skeptics of the trials, but I believe for the rest of us it provides reassurance that the pivotal trials supporting TPA under 3 hours were indeed positive," Dr.
Demand drivers for TPA continue to be region specific, according to the report.